J&J appoints Anuj Virmani as new MD of its medtech India division His priorities as the Managing Director of Johnson & Johnson medtech India encompass ethical leadership, nurturing talent, and…
MSF lauds Indian Patent Office’s rejection of J&J’s plea to extend monopoly on bedaquiline J&J must not block the supply of more affordable generic versions of bedaquiline to high TB burden countries and stand by its…
J&J to pay Rs 74.5 lakh to first patient with faulty hip implant: CDSCO This is the first case where M/s Johnson & Johnson has been directed to pay compensation for its faulty ASR hip implant
